Stay updated on Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing v3.6.3, indicating a minor revision to the study record page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating a newer version of the study record. This change updates the metadata at the bottom of the page to reflect the latest revision.SummaryDifference0.1%

- Check51 days agoChange DetectedRecruitment status now indicates no participants are being sought, and new user guidance sections were added to help readers navigate the study record and participate; a heading formatting update was applied to the Intervention/Treatment section.SummaryDifference0.4%

- Check58 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This indicates a recent update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check79 days agoChange DetectedThe revision label on the study page was updated from v3.5.3 to v3.5.4, indicating a newer version of the record. No substantive study details are affected in the provided information.SummaryDifference0.1%

- Check101 days agoChange DetectedClinicalTrials.gov now shows a newer platform release revision number for the page (v3.5.3 instead of v3.5.2), indicating a technical/site update rather than a change to the study record content.SummaryDifference0.1%

Stay in the know with updates to Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.